Ya well: In all due respects to Ole GibbyI am long as well ,the only difference being that Gibby has trouble seeing the ''forest for the trees'', but for that very minimal deficiency ,we shall not criticize. ---That being said,I have been here since PHM , when Daldon bought Black Bear Medical ,in Conway ,NH ,so over the years I have been in and out with portions of my portfolio.---Ok ,fast forward to the latest deal. All very good ,and comparing to Cooley a few years ago .: Same amount of clients , half the cost ,good payor network, good growth area. Cooley had 37% mobility,this new acquisition has 44% . Actually, a greater potential for the cross sell into respiratory , and THUS, potentially high internal growth . --- I continue to like Crawford's 5-15 mil acquisition strategy , and with the hiring of a very competent man in the fold, I have no reason to think this goes higher quite quickly . At this point in time, one should just relax ,and watch their portfolio rise in value ,as we go on .